Summary:
- This article discusses a new mRNA-based flu vaccine that is currently in clinical trials. mRNA vaccines work by providing the body with instructions to produce a specific protein found on the flu virus, which then triggers an immune response.
- The mRNA flu vaccine is designed to be more effective and adaptable than traditional flu shots, as it can be quickly updated to target new flu strains as they emerge.
- Preliminary results from the clinical trials show the mRNA flu vaccine is safe and generates a strong immune response, suggesting it could be a promising alternative to conventional flu vaccines in the future.